Crude Oil (CL)

에 대한 최신 뉴스 Colgate-Palmolive (NYSE:CL) 주식

Colgate-Palmolive

Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.

Equities

News

Previews

Tech

Trading Ideas

ABBV

AGYS

ASML

BJRI

CHKP

CHTR

CMCSA

DECK

GATX

GOOG

GOOGL

JNPR

NFLX

NXPI

ODFL

ORLY

SKYW

SPOT

TSLA

VRSN

S&amp;P 500 기업들 중 약 14%가 6월 분기 실적을 발표했으며, 더 넓은 지수를 구성하는 기업들의 혼합 실적 성장률은 여전히 ​​양호하다. 이번 주에는 기술 보고 시즌이 공식적으로 시작될 것이며, 이는 최근 주에 가파른 하락세를 보인 시장의 향방을 잠재적으로 결정할 수 있다.

테슬라, 알파벳, GM 및 포드가 이번 주 실적 발표 주도하며 상승세 유지 위해 고군분투

Colgate-Palmolive Co

Core One Labs Inc

CHINA LIAONING DINGXU ECO by China Liaoning Dingxu Ecological Agriculture Development, Inc.

China Liaoning Dingxu Ecological Agriculture Development Inc

Clarus Corp

CHAVANT CAPITAL ACQUISITION CORP UNIT 1 COM & 1/3 WT EXP

CLARITAS PHARMACICLS INC by CLARITAS PHARMACEUTICALS INC.

Claritas Pharmaceuticals Inc

Core Laboratories Inc

CALBEE Inc

Columbia Financial Inc

CALIBER ENERGY INC by Caliber Energy, Inc.

Colombier Acquisition Corp. II Class A Ordinary Shares

Colombier Acquisition Corp II

Colombier Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant

Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share

Colombier Acquisition Corp. II

Cellebrite DI Ltd

CORE LABORATORIES ORD

CHRISTINA LAKE CANNABIS by Christina Lake Cannabis Corp.

Christina Lake Cannabis Corp

CLICKS GROUP LTD S/ADR by Clicks Group Ltd

Clicks Group Ltd

CENTRAL CHINA SECS S/ADR by Central China Securities Co. Ltd.

Calcol Inc

Sinch AB

Cool Co Ltd

CEL Corp

Cell Source Inc

CapitaLand China Trust

Calidi Biotherapeutics, Inc. Common Stock

Calidi Biotherapeutics Inc

Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share

Direxion Daily Cloud Computing Bull 2X Shares

Chatham Lodging Trust (REIT) Common Shares of Beneficial Interest

Chatham Lodging Trust

Chatham Lodging Trust (REIT) 6.625% Series A Cumulative Redeemable Preferred Shares of Beneficial Interest

CLOUD3 VENTURES INC by CLOUD3 VENTURES INC

Cloud3 Ventures Inc

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics Inc

CELLDEX THERAPEUTICS ORD

Coles Group Ltd

COLES GROUP LTD UNSP/ADR by Coles Group Ltd.

AMUNDI IDX EMERGING ESG BROAD ETF

China Liberal Education Holdings Limited - Ordinary Shares

China Liberal Education Holdings Ltd

CONCRETE LEVELING SYS INC by Concrete Leveling Systems Inc.

Concrete Leveling Systems Inc

Cleveland-Cliffs Inc

Clearfield Inc

CLIFFORD MDERN IVING HLD by CLIFFORD MODERN LIVING HLDGS LTD.

CLEVELAND CLIFFS ORD

CLARITY METALS CORP by Clarity Metals Corp.

Clarity Metals Corp

Aris Mining Corp

CLEGHORN MINERALS ORD by Cleghorn Minerals

Cleghorn Minerals Ltd

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies Ltd

CLEANGO INNOVATIONS INC by CleanGo Innovations Inc.

CleanGo Innovations Inc

CLEAN SEED CAP GROUP LTD by Clean Seed Capital Group Ltd

Clean Seed Capital Group Ltd

Cloud Nine Web3 Technologies Inc

HUTECH21 CO LTD NEW by Hutech21 Co., Ltd.

Hutech21 Co Ltd

Clean Harbors Inc

ClearDAO

CLST Holdings Inc

COLTENE HOLDING AG ORD by Coltene Holding AG

Coltene Holding AG

Tidal Trust II Veridien Climate Action ETF

Climate Real Impact Solutions III Acquisition

Energy Plug Technologies Corp

CORDLIFE GROUP LTD ORD by Cordlife Group Ltd

Cordlife Group Ltd

CLS HOLDINGS PLC ORD by CLS Holdings Plc.

CLS Holdings PLC

CLICK HOLDINGS LTD USD ORD SHS

CAPITALAND INVESTMENT LTD by Capitaland Investment Ltd.

CapitaLand Investment Ltd

UBS CLIMATE AWARE GLOBAL UCITS ETF

CLEAN EARTH ACQUISITIONS CORP RT

CLEAN EARTH ACQUISITIONS CORP UNIT 1 CL A COM & 1 RT 1/2 RED WT EXP

CLEAN EARTH ACQUISITIONS CORP RED WT EXP

Global X Funds Global X 1-3 Month T-Bill ETF

GLOBAL X 1-3 MONTH T-BILL USD AC ETF

ClearSign Technologies Corporation - Common Stock

ClearSign Technologies Corp

CLEARFORD WATER SYS INC by Clearford Water Systems, Inc.

Clearford Water Systems Inc

CLICKSTREAM CORP by ClickStream Corporation

ClickStream Corp

CITY OF LONDON INVST GRP by City of London Investment Group PLC

City of London Investment Group PLC

ProShares Long Online/Short Stores ETF

Clarke Inc

Calcitech Ltd

TWC ENTERPRISES LTD ORD by TWC Enterprises Ltd.

TWC Enterprises Ltd

CLAYTON & LAMBERT MFG CO by Clayton & Lambert Manufacturing Co.

CoLabs IntL Corp

CHALLENGER GOLD LIMITED by Challenger Gold Limited

Challenger Gold Ltd

COLLINS FOODS LTD NWMKT by Collins Foods Ltd Newmarket Qld

Collins Foods Ltd

BICO Group AB

COLLECTIVE METALS INC by COLLECTIVE METALS INC.

Collective Metals Inc

CELLNEX TELECOM UNSP/ADR by Cellnex Telecom SA

Cellnex Telecom SA

Cellectis S.A. - American Depositary Shares

Cellectis SA

CALLINEX MINES INC by Callinex Mines Inc.

Callinex Mines Inc

Cornerstone Strategic Value Fund, Inc. New Common Stock

Cornerstone Strategic Value Fund Inc

GUINNESS SUST ENERGY UCITS ETF GBX

Climb Global Solutions, Inc. - Common Stock

Climb Global Solutions Inc

CALIMA ENERGY LTD NEW by Calima Energy Ltd.

Calima Energy Ltd

CALGRO M3 HOLDINGS LTD by Calgro M3 Holdings Ltd.

Calgro M3 Holdings Ltd

Climeon AB

CANADIAN PREM SAND by Canadian Prem Sand Inc.

Canadian Premium Sand Inc

Looking into the current session, Colgate-Palmolive Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) shares are trading at $102.50, after a 1.20% decrease. Over the past month, the stock fell by 2.73%, but over the past year, it actually went up by 44.73%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2024/1727376314_0.png" alt="Past Year Chart" />

<h3>A Look at Colgate-Palmolive P/E Relative to Its Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 45.41 in the Household Products industry, Colgate-Palmolive Inc. has a lower P/E ratio of 30.25. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1727376314_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

Price Over Earnings Overview: Colgate-Palmolive

Investors with a lot of money to spend have taken a bullish stance on Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CL, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for Colgate-Palmolive.
This isn't normal.
The overall sentiment of these big-money traders is split between 90% bullish and 10%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $32,560, and 9, calls, for a total amount of $794,180.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $97.5 to $110.0 for Colgate-Palmolive over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Colgate-Palmolive's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Colgate-Palmolive's significant trades, within a strike price range of $97.5 to $110.0, over the past month.
<h3>Colgate-Palmolive Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727283650_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/11/24</td>
<td>$5.5</td>
<td>$5.4</td>
<td>$5.5</td>
<td>$99.00</td>
<td>$110.0K</td>
<td style="text-align: right;">1</td>
<td>1.4K</td>
</tr>
<tr>
<td>CL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/11/24</td>
<td>$5.5</td>
<td>$5.2</td>
<td>$5.5</td>
<td>$99.00</td>
<td>$110.0K</td>
<td style="text-align: right;">1</td>
<td>1.0K</td>
</tr>
<tr>
<td>CL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/11/24</td>
<td>$5.5</td>
<td>$5.4</td>
<td>$5.5</td>
<td>$99.00</td>
<td>$109.8K</td>
<td style="text-align: right;">1</td>
<td>1.6K</td>
</tr>
<tr>
<td>CL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/11/24</td>
<td>$5.5</td>
<td>$5.4</td>
<td>$5.5</td>
<td>$99.00</td>
<td>$109.8K</td>
<td style="text-align: right;">1</td>
<td>1.2K</td>
</tr>
<tr>
<td>CL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/11/24</td>
<td>$5.4</td>
<td>$5.2</td>
<td>$5.4</td>
<td>$99.00</td>
<td>$107.8K</td>
<td style="text-align: right;">1</td>
<td>600</td>
</tr>
</tbody>
</table>

<h3>About Colgate-Palmolive</h3>
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.
In light of the recent options history for Colgate-Palmolive, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Colgate-Palmolive's Current Market Status</h3>
<ul>
<li>Trading volume stands at 845,127, with CL's price down by -0.07%, positioned at $103.72.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 30 days.</li>
</ul>
<h3>Expert Opinions on Colgate-Palmolive</h3>
4 market experts have recently issued ratings for this stock, with a consensus target price of $113.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Wells Fargo lowers its rating to Underweight with a new price target of $100. 
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Colgate-Palmolive, which currently sits at a price target of $122. 
&#x2A; An analyst from Piper Sandler has revised its rating downward to Overweight, adjusting the price target to $121. 
&#x2A; Reflecting concerns, an analyst from Deutsche Bank lowers its rating to Hold with a new price target of $109.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Colgate-Palmolive with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Check Out What Whales Are Doing With Colgate-Palmolive

Piper Sandler analyst Korinne Wolfmeyer initiates coverage on Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Overweight rating and announces Price Target of $121.

Price Target

Initiation

Analyst Ratings

Piper Sandler Initiates Coverage On Colgate-Palmolive with Overweight Rating, Announces Price Target of $121

Deep-pocketed investors have adopted a bullish approach towards Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CL usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Colgate-Palmolive. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 2 are puts, totaling $61,200, and 6 are calls, amounting to $228,304.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $95.0 and $105.0 for Colgate-Palmolive, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Colgate-Palmolive options trades today is 881.17 with a total volume of 1,167.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Colgate-Palmolive's big money trades within a strike price range of $95.0 to $105.0 over the last 30 days.
<h3>Colgate-Palmolive Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727111761_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$8.5</td>
<td>$8.3</td>
<td>$8.5</td>
<td>$97.50</td>
<td>$55.2K</td>
<td>520</td>
<td style="text-align: right;">100</td>
</tr>
<tr>
<td>CL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$0.95</td>
<td>$0.9</td>
<td>$0.95</td>
<td>$105.00</td>
<td>$48.0K</td>
<td>2.6K</td>
<td style="text-align: right;">530</td>
</tr>
<tr>
<td>CL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$7.5</td>
<td>$7.2</td>
<td>$7.48</td>
<td>$97.50</td>
<td>$37.4K</td>
<td>612</td>
<td style="text-align: right;">92</td>
</tr>
<tr>
<td>CL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$4.6</td>
<td>$4.5</td>
<td>$4.5</td>
<td>$95.00</td>
<td>$34.2K</td>
<td>250</td>
<td style="text-align: right;">76</td>
</tr>
<tr>
<td>CL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/27/24</td>
<td>$4.1</td>
<td>$4.0</td>
<td>$4.0</td>
<td>$100.00</td>
<td>$30.8K</td>
<td>195</td>
<td style="text-align: right;">192</td>
</tr>
</tbody>
</table>

<h3>About Colgate-Palmolive</h3>
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.
In light of the recent options history for Colgate-Palmolive, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Colgate-Palmolive</h3>
<ul>
<li>Trading volume stands at 1,380,483, with CL's price up by 0.51%, positioned at $103.59.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 32 days.</li>
</ul>
<h3>Expert Opinions on Colgate-Palmolive</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $110.33333333333333.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo has revised its rating downward to Underweight, adjusting the price target to $100. 
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Colgate-Palmolive, which currently sits at a price target of $122. 
&#x2A; An analyst from Deutsche Bank has revised its rating downward to Hold, adjusting the price target to $109. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Colgate-Palmolive, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Unpacking the Latest Options Trading Trends in Colgate-Palmolive

Wells Fargo analyst Chris Carey downgrades Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) from Equal-Weight to Underweight and announces $100 price target.

Downgrades

Wells Fargo Downgrades Colgate-Palmolive to Underweight, Announces $100 Price Target

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page.</a>
<ul>
<li>Ascendiant Capital raised the price target for Pro-Dex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDEX#NASDAQ">PDEX</a>) from $28 to $30. Ascendiant Capital analyst Edward Woo maintained a Buy rating. Pro-Dex shares gained 4.2% to close at $23.28 on Friday. <a href="https://www.benzinga.com/quote/PDEX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>HC Wainwright &amp; Co. boosted the price target for Summit Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) from $16 to $30. HC Wainwright &amp; Co. analyst Mitchell Kapoor maintained a Buy rating. Summit Therapeutics shares fell 1.8% to close at $12.27 on Friday. <a href="https://www.benzinga.com/quote/MEI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan raised United States Steel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) price target from $40 to $42. JP Morgan analyst Bill Peterson upgraded the stock from Neutral to Overweight. United States Steel shares gained 4.3% to close at $31.27 on Friday. <a href="https://www.benzinga.com/quote/SMMT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Morgan Stanley raised Costco Wholesale Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) price target from $855 to $950. Morgan Stanley analyst Simeon Gutman maintained an Overweight rating. Costco shares fell 1.1% to close at $876.68 on Friday. <a href="https://www.benzinga.com/quote/COST/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wedbush boosted the price target for LGI Homes, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGIH#NASDAQ">LGIH</a>) from $97 to $125. Wedbush analyst Jay McCanless upgraded the stock from Underperform to Neutral. LGI Homes shares rose 0.8% to close at $104.80 on Friday. <a href="https://www.benzinga.com/quote/LGIH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>BTIG increased Roblox Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) price target from $47 to $51. BTIG analyst Clark Lampen maintained a Buy rating. Roblox shares fell 0.2% to close at $43.64 on Friday. <a href="https://www.benzinga.com/quote/RBLX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities raised JetBlue Airways Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) price target from $3 to $6. B of A Securities analyst Andrew Didora upgraded the stock from Underperform to Neutral. JetBlue shares fell 1.7% to close at $5.30 on Friday. S<a href="https://www.benzinga.com/quote/JBLU/analyst-ratings">ee how other analysts view this stock.</a></li>
<li>Deutsche Bank increased the price target for Colgate-Palmolive Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) from $107 to $109. Deutsche Bank analyst Steve Powers downgraded the stock from Buy to Hold. Colgate-Palmolive shares fell 0.6% to close at $107.86 on Friday. See how other analysts view this stock.</li>
<li>JP Morgan boosted Nucor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) price target from $170 to $174. JP Morgan analyst Bill Peterson upgraded the stock from Neutral to Overweight. Nucor shares fell 0.6% to close at $138.79 on Friday. <a href="https://www.benzinga.com/quote/NUE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>BMO Capital boosted Starbucks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) price target from $100 to $110. BMO Capital analyst Andrew Strelzik maintained an Outperform rating. Starbucks shares fell 0.5% to close at $91.15 on Friday. <a href="https://www.benzinga.com/quote/SBUX/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying SBUX stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="506" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/09085953/image-70-1024x506.png" alt="" class="wp-image-537416" style="width:621px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/09085953/image-70-1024x506.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/09085953/image-70-300x148.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/09085953/image-70-768x380.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/09085953/image-70.png 1368w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>

Pre-Market Outlook

COST

JBLU

LGIH

PDEX

RBLX

SBUX

SMMT

Starbucks To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Monday

17 analysts have shared their evaluations of Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">8</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $106.0, a high estimate of $122.00, and a low estimate of $91.00. Surpassing the previous average price target of $100.67, the current average has increased by 5.29%.
<img src="https://www.benzinga.com/files/images/story/2024/1725886843_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A clear picture of Colgate-Palmolive's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$109.00</td>
<td>$107.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$122.00</td>
<td>$119.00</td>
</tr>
<tr>
<td>Robert Moskow</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$115.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Callum Elliott</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$103.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$107.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Dara Mohsenian</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$111.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$96.00</td>
<td>$91.00</td>
</tr>
<tr>
<td>Kaumil Gajrawala</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$95.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Robert Moskow</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Buy</td>
<td>$110.00</td>
<td>-</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$105.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$91.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Robert Ottenstein</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$106.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$104.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$112.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Bryan Spillane</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$110.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$97.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Kevin Grundy</td>
<td>Exane BNP Paribas</td>
<td>Announces</td>
<td>Outperform</td>
<td>$109.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Colgate-Palmolive. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Colgate-Palmolive compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Colgate-Palmolive's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Colgate-Palmolive analyst ratings.</a>
<h2>Delving into Colgate-Palmolive's Background</h2>
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.
<h3>Colgate-Palmolive's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Positive Revenue Trend: Examining Colgate-Palmolive's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.89% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Consumer Staples sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Colgate-Palmolive's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 14.45% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Colgate-Palmolive's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 414.16%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Colgate-Palmolive's ROA excels beyond industry benchmarks, reaching 4.42%. This signifies efficient management of assets and strong financial health.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 70.54, caution is advised due to increased financial risk.
<h2>The Significance of Analyst Ratings Explained</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Peeling Back The Layers: Exploring Colgate-Palmolive Through Analyst Insights

Deutsche Bank analyst Steve Powers downgrades Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) from Buy to Hold and raises the price target from $107 to $109.

Deutsche Bank Downgrades Colgate-Palmolive to Hold, Raises Price Target to $109

UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Buy and raises the price target from $119 to $122.

UBS Maintains Buy on Colgate-Palmolive, Raises Price Target to $122

Disclosed in a recent SEC filing on August 27, HUNDMEJEAN, Board Member at Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>), made a noteworthy transaction involving the exercise of company stock options.
What Happened: A notable Form 4 filing on Tuesday with the <a href="https://www.sec.gov/Archives/edgar/data/0000021665/000122520824008254//Archives/edgar/data/21665/000122520824008254/0001225208-24-008254-index.htm">U.S. Securities and Exchange Commission</a> revealed that HUNDMEJEAN, Board Member at Colgate-Palmolive, exercised stock options for 3,462 shares of CL, resulting in a transaction value of $128,440.
As of Wednesday morning, Colgate-Palmolive shares are up by 0.53%, with a current price of $106.48. This implies that HUNDMEJEAN's 3,462 shares have a value of $128,440.
<h3>Get to Know Colgate-Palmolive Better</h3>
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.
<h3>A Deep Dive into Colgate-Palmolive's Financials</h3>
Revenue Growth: Colgate-Palmolive displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 4.89%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Staples sector.
Navigating Financial Profits:
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 60.62%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Colgate-Palmolive's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 0.89.
</li>
</ul>
Debt Management: Colgate-Palmolive's debt-to-equity ratio surpasses industry norms, standing at 70.54. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
Analyzing Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 30.88 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 4.37 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio of 20.75, the company's market valuation exceeds industry averages.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Pay Attention to Insider Transactions</h3>
Investors should view insider transactions as part of a multifaceted analysis and not rely solely on them for decision-making.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Transaction Codes To Focus On</h3>
For <a href="https://www.benzinga.com/money/investing-tools">investors</a>, a primary focus lies on transactions occurring in the open market, as indicated in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000021665">Check Out The Full List Of Colgate-Palmolive's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

At Colgate-Palmolive, MARTINA HUNDMEJEAN Chooses To Exercise Options, Resulting In $128K

An initiative seeking to enable easier unionization in the cannabis industry in Oregon got the green light from the secretary of state's office to appear on the November ballot.
State officials confirmed that the campaign from the regional chapter of United Food and Commercial Workers (UFCW) collected enough verified signatures – over 160 000 &#8211; from voters.
UFCW Local 555 delivered <a href="https://www.benzinga.com/markets/cannabis/24/07/39685332/labor-peace-agreements-in-cannabis-and-higher-taxes-for-corporations-2-initiatives-likely-to-rea">more than 163,000 signatures for verification before the July 5 deadline</a>, which is about 46,000 more than required.
Measure 119, United for Cannabis Workers Act, seeks to "ensure that cannabis workers' freedoms to organize and bargain collectively are protected under state law," according to last week&#8217;s <a href="https://www.ufcw555.org/measure-119-qualifies/">press release</a>. "No one would be required to join a union, but workers would have the freedom to do so if they choose."
The latest push from UFCW follows its failed attempt to reform the cannabis landscape. In 2023, the union pushed for the passage of House Bill 2183, a similar measure, but the bill was tabled due to concerns it would conflict with federal law.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/04/38411661/cannabis-de-unionization-heres-whats-new-on-the-frontlines-of-labor-organizing-among-weed-worker">Cannabis (De)Unionization: Here&#8217;s What&#8217;s New On The Frontlines Of Labor Organizing Among Weed Workers</a> 
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/09114759/CCC-Oct-24-Banner-1-31.gif" alt="" class="wp-image-487293" /></a></figure>
"Workers across every industry should have the freedom to unionize if they so choose," Dan Clay, president of UFCW Local 555, said in a press release. "This ballot measure closes an age-old loophole that deprives that right to thousands of Oregon cannabis workers."
Clay cautioned that "shady cannabis tycoons have taken advantage of an outdated law to strip workers' rights that are guaranteed to nearly every other American. By passing Measure 119, voters will enshrine the freedom to unionize in the Oregon Cannabis industry."
The policy reform effort is supported by the Oregon AFL-CIO and Oregon Working Families Party, as well as a number of state and local officials.
Meanwhile, marijuana workers at a production facility in Joliet, Illinois, operated by cannabis company Cresco Labs Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#CSE">CL</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTCQX">CRLBF</a>) (FSE: 6CQ) recently voted to leave their union – United Food &amp; Commercial Workers.
Jonathan Keselenko, a partner in Foley Hoag&#8217;s cannabis practice in Boston, told the outlet that this move seems to indicate that the excitement for unionization among cannabis workers is fading, as recently highlighted by Benzinga's <a href="https://www.benzinga.com/author/nina-zdinjak">Nina Zdinjak</a>. In April, employees at Cresco's Massachusetts cultivation facility voted to de-unionize, instead of negotiating another <a href="https://www.benzinga.com/markets/cannabis/24/07/39604013/paying-dues-for-nothing-cannabis-workers-at-cresco-labs-illinois-facility-leave-the-union-get-15">labor deal as its contract neared expiration.</a>
Read Next
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/08/40259646/cannabis-co-cresco-labs-q2-gross-profit-increases-over-9-yoy-reports-nearly-7-drop-in-revenue">Cannabis Co. Cresco Lab&#8217;s Q2 Gross Profit Increases Over 9% YoY, Reports Nearly 7% Drop In Revenue</a></li>
</ul>

Comments

Colgate-Palmolive

뉴스

에 대한 최신 뉴스 Colgate-Palmolive (NYSE:CL) 주식

일요일, 7월 21, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌